These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 23675550)

  • 1. Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.
    Buxbaum LU
    PLoS Negl Trop Dis; 2013; 7(5):e2224. PubMed ID: 23675550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.
    Thomas BN; Buxbaum LU
    Infect Immun; 2008 Feb; 76(2):623-31. PubMed ID: 18070890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor 2 (TLR2) plays a role in controlling cutaneous leishmaniasis in vivo, but does not require activation by parasite lipophosphoglycan.
    Halliday A; Bates PA; Chance ML; Taylor MJ
    Parasit Vectors; 2016 Oct; 9(1):532. PubMed ID: 27716391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-10 from T cells, but not macrophages and granulocytes, is required for chronic disease in Leishmania mexicana infection.
    Buxbaum LU
    Infect Immun; 2015 Apr; 83(4):1366-71. PubMed ID: 25605773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface antigens of Leishmania mexicana amastigotes: characterization of glycoinositol phospholipids and a macrophage-derived glycosphingolipid.
    Winter G; Fuchs M; McConville MJ; Stierhof YD; Overath P
    J Cell Sci; 1994 Sep; 107 ( Pt 9)():2471-82. PubMed ID: 7844164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A detrimental role for IgG and FcgammaR in Leishmania mexicana infection.
    Buxbaum LU
    Immunol Res; 2008; 42(1-3):197-209. PubMed ID: 19002608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of the murine interleukin-4 gene inhibits disease progression during Leishmania mexicana infection but does not increase control of Leishmania donovani infection.
    Satoskar A; Bluethmann H; Alexander J
    Infect Immun; 1995 Dec; 63(12):4894-9. PubMed ID: 7591152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycoinositol phospholipids from American Leishmania and Trypanosoma spp: partial characterization of the glycan cores and the human humoral immune response to them.
    Avila JL; Rojas M; Acosta A
    J Clin Microbiol; 1991 Oct; 29(10):2305-12. PubMed ID: 1719024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgG1 is pathogenic in Leishmania mexicana infection.
    Chu N; Thomas BN; Patel SR; Buxbaum LU
    J Immunol; 2010 Dec; 185(11):6939-46. PubMed ID: 21037092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-4 Responsive Dendritic Cells Are Dispensable to Host Resistance Against
    Osero BO; Cele Z; Aruleba RT; Maine RA; Ozturk M; Lutz MB; Brombacher F; Hurdayal R
    Front Immunol; 2021; 12():759021. PubMed ID: 35154068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The glycoinositol phospholipids of Leishmania mexicana promastigotes. Evidence for the presence of three distinct pathways of glycolipid biosynthesis.
    McConville MJ; Collidge TA; Ferguson MA; Schneider P
    J Biol Chem; 1993 Jul; 268(21):15595-604. PubMed ID: 8340385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term protection conferred by Leishvacin® against experimental Leishmania amazonensis infection in C57BL/6 mice.
    Carneiro MB; de Andrade e Sousa LM; Vaz LG; Dos Santos LM; Vilela L; de Souza CC; Gonçalves R; Tafuri WL; Afonso LC; Côrtes DF; Vieira LQ
    Parasitol Int; 2014 Dec; 63(6):826-34. PubMed ID: 25102355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 10- and Fcgamma receptor-deficient mice resolve Leishmania mexicana lesions.
    Buxbaum LU; Scott P
    Infect Immun; 2005 Apr; 73(4):2101-8. PubMed ID: 15784551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early enhanced Th1 response after Leishmania amazonensis infection of C57BL/6 interleukin-10-deficient mice does not lead to resolution of infection.
    Jones DE; Ackermann MR; Wille U; Hunter CA; Scott P
    Infect Immun; 2002 Apr; 70(4):2151-8. PubMed ID: 11895981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycoinositol-phospholipid profiles of four serotypically distinct Old World Leishmania strains.
    Schneider P; Schnur LF; Jaffe CL; Ferguson MA; McConville MJ
    Biochem J; 1994 Dec; 304 ( Pt 2)(Pt 2):603-9. PubMed ID: 7998997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute cysticercosis favours rapid and more severe lesions caused by Leishmania major and Leishmania mexicana infection, a role for alternatively activated macrophages.
    Rodríguez-Sosa M; Rivera-Montoya I; Espinoza A; Romero-Grijalva M; López-Flores R; González J; Terrazas LI
    Cell Immunol; 2006 Aug; 242(2):61-71. PubMed ID: 17118349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leishmania mexicana induces limited recruitment and activation of monocytes and monocyte-derived dendritic cells early during infection.
    Petritus PM; Manzoni-de-Almeida D; Gimblet C; Gonzalez Lombana C; Scott P
    PLoS Negl Trop Dis; 2012; 6(10):e1858. PubMed ID: 23094119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An in vitro model of antibody-enhanced killing of the intracellular parasite Leishmania amazonensis.
    Gibson-Corley KN; Bockenstedt MM; Li H; Boggiatto PM; Phanse Y; Petersen CA; Bellaire BH; Jones DE
    PLoS One; 2014; 9(9):e106426. PubMed ID: 25191842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Determination of the specificity of seric IgA produced in response to antigens of Leishmania (Leishmania) mexicana in murine leishmaniasis].
    Pérez-Aguilar MC; Hernández O; Maizo de Segnini Z; Rojas CH; Díaz S; Alarcón M; Goncalves L
    Invest Clin; 2011 Sep; 52(3):216-29. PubMed ID: 21950193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type I IFNs promote the early IFN-gamma response and the IL-10 response in Leishmania mexicana infection.
    Buxbaum LU
    Parasite Immunol; 2010 Feb; 32(2):153-60. PubMed ID: 20070829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.